CORE Biomedicine
PrivateLast Round
Series A
Jul 28, 2026
Total Funding Raised
$21M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CORE Biomedicine is a biotechnology company that develops therapeutic approaches for the treatment of luminal cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CORE Biomedicine Comparables
Compare CORE Biomedicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flare Therapeutics | 83% | |
| Antares Therapeutics | 76% | |
| RIANA Therapeutics | 73% | |
CORE Biomedicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2026 | ||||
| Series A | Sep 13, 2025 | ||||
| Seed | Mar 14, 2025 |
CORE Biomedicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| Mitsubishi UFJ Capital | Series A |
| Root Venture Partners | Series A |
| Elēkrŏn Ventures | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series A, Seed |
| Vision Incubate Co., Ltd. | Series A, Seed |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2025
Raised Series A with UTokyo Innovation Platform and Vision Incubate.
- Mar 14, 2025
Seed round with UTokyo Innovation Platform and Vision Incubate.
CORE Biomedicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CORE Biomedicine's valuation, stock price, and market status.